Refractory Neurofibromatosis Type 1
1 clinical trials · Condition
◉ Watch Refractory Neurofibromatosis Type 1
| Record | Firm | Date |
|---|---|---|
| Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma (NCT01089101) | National Cancer Institute (NCI) | 2010-07-07 |
Track Refractory Neurofibromatosis Type 1 automatically
Every clearance here is in the API, with alerts when new ones post.